Top compounds associated with response to TTYH3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.009
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.13 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.01
mRNA cediranib CTRPv2 pan-cancer AAC 0.15 0.01
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.22 0.01
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.097 0.01
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA alvocidib CTRPv2 pan-cancer AAC 0.13 0.01
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.081 0.01
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.01
Download CSV